U.S. Government Purchases Additional 100 Million Doses of Moderna's COVID-19 Vaccine

Tennessee Tribune | Nashville

Feb 12, 2021

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 11, 2021-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced…